The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 243 results:
Author [ Title(Desc)] Type Year
Filters: Author is Karagiannis, Asterios  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Athyros, V. G., Gossios T. D., Tziomalos K., Florentin M., Karagiannis A., & Mikhailidis D. P. (2011).  Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?. Arch Med Sci. 7(6), 1067-75.
Katsiki, N., Kollari E., Dardas S., Dardas P., Haidich A-B., Athyros V. G., et al. (2016).  Is There an Association Between Carotid-Femoral Pulse Wave Velocity and Coronary Heart Disease in Patients with Coronary Artery Disease: A Pilot Study.. Open Cardiovasc Med J. 10, 64-8.
Theocharidou, E., Gossios T. D., Griva T., Giouleme O., Douma S., Athyros V. G., et al. (2014).  Is there an association between inflammatory bowel diseases and carotid intima-media thickness? Preliminary data.. Angiology. 65(6), 543-50.
Anagnostis, P., Athyros V. G., Kita M., & Karagiannis A. (2013).  Is there any association between adiponectin gene polymorphisms and cardiovascular disease?. Angiology. 64(4), 253-6.
Patoulias, D., Katsimardou A., Kalogirou M-S., Karagiannis A., & Doumas M. (2019).  Is there any place for sodium-glucose co-transporter-2 inhibitors in post-liver transplantation patients?. Dig Liver Dis.
Katsiki, N., Koumaras C., Athyros V. G., & Karagiannis A. (2012).  Thinking beyond traditional cardiovascular risk factors: the role of arterial stiffness in targeting residual risk.. Angiology. 63(1), 9-11.
Athyros, V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2010).  To switch (statins) or not to switch? That is the question.. Expert Opin Pharmacother. 11(18), 2943-6.
Doumas, M., Athyros V., & Karagiannis A. (2015).  Transcatheter Renal Sympathetic Denervation: Chasing a Chimera or a Matter of Technological Improvements?. Cardiology. 131(3), 186-8.
Athyros, V. G., Katsiki N., & Karagiannis A. (2014).  Treating heart failure with preserved ejection fraction: statins could make the difference.. Angiology. 65(4), 328-9.
Krikis, N., Tziomalos K., Perifanis V., Vakalopoulou S., Karagiannis A., Garypidou V., et al. (2004).  Treatment of recurrent gastrointestinal haemorrhage in a patient with von Willebrand's disease with administration of octreotide LAR and propranolol.. Hormones (Athens). 3(1), 65-7.
Athyros, V. G., Tziomalos K., & Karagiannis A. (2015).  Treatment options for dyslipidemia in chronic kidney disease and for protection from contrast-induced nephropathy.. Expert Rev Cardiovasc Ther. 13(9), 1059-66.
Tziomalos, K., Athyros V. G., Karagiannis A., Kolovou G. D., & Mikhailidis D. P. (2009).  Triglycerides and vascular risk: insights from epidemiological data and interventional studies.. Curr Drug Targets. 10(4), 320-7.
U
Karagiannis, A., Tziomalos K., Krikis N., Sfikas G., Dona K., & Zamboulis C. (2005).  The unilateral measurement of blood pressure may mask the diagnosis or delay the effective treatment of hypertension.. Angiology. 56(5), 565-9.
Anagnostis, P., Stangou M., Leontsini M., Athyros V. G., & Karagiannis A. (2008).  Unusual manifestation of diarrhea-associated haemolytic uraemic syndrome in an adult.. Ren Fail. 30(3), 331-4.
Athyros, V. G., Alexandrides T. K., Bilianou H., Cholongitas E., Doumas M., Ganotakis E. S., et al. (2017).  The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement. Metabolism. 71, 17 - 32.
Athyros, V. G., Alexandrides T. K., Bilianou H., Cholongitas E., Doumas M., Ganotakis E. S., et al. (2017).  The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.. Metabolism. 71, 17-32.
V
Vyzantiadis, T., Karagiannis A., Douma S., Harsoulis P., Vyzantiadis A., & Zamboulis C. (2006).  Vascular endothelial growth factor and nitric oxide serum levels in arterial hypertension.. Clin Exp Hypertens. 28(7), 603-9.
Anagnostis, P., Athyros V. G., Adamidou F., Florentin M., & Karagiannis A. (2010).  Vitamin D and cardiovascular disease: a novel agent for reducing cardiovascular risk?. Curr Vasc Pharmacol. 8(5), 720-30.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.